KTE-X19 (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Mantle Cell Lymphoma

Pending FDA approval for adults with relapsed or refractory mantle cell lymphoma (MCL)

Next:

Pharmacology

Mechanism of Action

Anti-CD19 CAR-T therapy

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.